Pfister, David

Publications

Sort by

Co-Author Network

selected publications

Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers. The Journal of clinical endocrinology and metabolism. 2019 Academic Article GET IT
Times cited: 126
Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Academic Article GET IT
Times cited: 103
Challenges and Opportunities for Developing New Therapeutics for Salivary Gland Cancers. Journal of oncology practice. 2018 Letter GET IT
Times cited: 3
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer. Cancer. 2017 Academic Article GET IT
Times cited: 47
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Academic Article GET IT
Times cited: 452
The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform. JAMA oncology. 2017 Academic Article GET IT
Times cited: 158
White adipose tissue inflammation and cancer-specific survival in patients with squamous cell carcinoma of the oral tongue. Cancer. 2016 Academic Article GET IT
Times cited: 38
Unmet needs for patients with salivary gland cancer. Oral oncology. 2016 Editorial Article GET IT
Times cited: 6
Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal Carcinoma. International journal of radiation oncology, biology, physics. 2016 Academic Article GET IT
Times cited: 107
Patterns of regional and distant metastasis in esthesioneuroblastoma. The Laryngoscope. 2016 Academic Article GET IT
Times cited: 44
Risk Adjusting Survival Outcomes in Hospitals That Treat Patients With Cancer Without Information on Cancer Stage. JAMA oncology. 2015 Academic Article GET IT
Times cited: 91
Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma. Head & neck. 2015 Academic Article GET IT
Times cited: 27
Head and Neck Cancers, Version 1.2015. Journal of the National Comprehensive Cancer Network : JNCCN. 2015 Academic Article GET IT
Times cited: 171
Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximab. Head & neck. 2015 Academic Article GET IT
Times cited: 26
Reply to B. O'Sullivan et Al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Letter GET IT
Times cited: 6
Evaluating the potential role of PET/CT in the posttreatment surveillance of head and neck cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2015 Conference Paper GET IT
Times cited: 4
Treatment-related toxicities in older adults with head and neck cancer: A population-based analysis. Cancer. 2015 Academic Article GET IT
Times cited: 46
Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. 2014 GET IT
Times cited: 179
New chapter in our understanding of human papillomavirus-related head and neck cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Editorial Article GET IT
Times cited: 11
Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC). Oral oncology. 2014 Academic Article GET IT
Times cited: 48
A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer. Investigational new drugs. 2014 Academic Article GET IT
Times cited: 5
Causes of death in long-term survivors of head and neck cancer. Cancer. 2014 Academic Article GET IT
Times cited: 149
Anaplastic thyroid carcinoma: a 25-year single-institution experience. Annals of surgical oncology. 2014 Academic Article GET IT
Times cited: 74
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC). Annals of oncology : official journal of the European Society for Medical Oncology. 2014 Academic Article GET IT
Times cited: 18
Impact of obesity on the survival of patients with early-stage squamous cell carcinoma of the oral tongue. Cancer. 2014 Academic Article GET IT
Times cited: 51
Value considerations in the treatment of head and neck cancer: radiation, chemotherapy, and supportive care. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2014 Review GET IT
Times cited: 7
A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer. International journal of radiation oncology, biology, physics. 2013 Academic Article GET IT
Times cited: 51
Early salvage radiotherapy following radical prostatectomy. European urology. 2013 Review GET IT
Times cited: 150
Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. 2013 GET IT
Times cited: 134
Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinoma. Thyroid : official journal of the American Thyroid Association. 2013 Academic Article GET IT
Times cited: 60
Prostate cancer: in favour of active surveillance--functional outcomes matter. Nature reviews. Urology. 2013 Article GET IT
Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer. International journal of cancer. 2013 Academic Article GET IT
Times cited: 31
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. The New England journal of medicine. 2013 Academic Article GET IT
Times cited: 584
A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer. Cancer. 2013 Academic Article GET IT
Times cited: 37
Sharing a diagnosis of HPV-related head and neck cancer: the emotions, the confusion, and what patients want to know. Head & neck. 2012 Academic Article GET IT
Times cited: 47
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2012 Academic Article GET IT
Times cited: 29
Molecular-targeted therapies in head and neck cancer. Seminars in radiation oncology. 2012 Academic Article GET IT
Times cited: 7
A phase I study of temsirolimus plus carboplatin plus paclitaxel for patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC). Cancer chemotherapy and pharmacology. 2012 Academic Article GET IT
Times cited: 29
Hemorrhagic pseudoaneurysm in a patient receiving aflibercept for metastatic thyroid cancer. 2012 GET IT
Times cited: 3
A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer. Cancer. 2012 Academic Article GET IT
Times cited: 65
Mucosal melanoma of the head and neck. 2012 GET IT
TALK score: Development and validation of a prognostic model for predicting larynx preservation outcome. The Laryngoscope. 2012 Academic Article GET IT
Times cited: 23
Off-label use of oncology drugs: the need for more data and then some. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Editorial Article GET IT
Times cited: 34
Selective radiotherapy for the treatment of head and neck Merkel cell carcinoma. Cancer. 2011 Academic Article GET IT
Times cited: 21
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial. The Lancet. Oncology. 2011 Academic Article GET IT
Times cited: 264
Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2011 Academic Article GET IT
Times cited: 75
A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors. Cancer chemotherapy and pharmacology. 2011 Academic Article GET IT
Times cited: 38
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer. 2011 GET IT
Times cited: 255
Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes. International journal of radiation oncology, biology, physics. 2011 Academic Article GET IT
Times cited: 57
Current recommendations for systemic therapy of recurrent and/or metastatic head and neck squamous cell cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2011 Review GET IT
Times cited: 27
Head and neck cancers. 2011 GET IT
Times cited: 156
Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Academic Article GET IT
Times cited: 477
Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases. International journal of radiation oncology, biology, physics. 2011 Academic Article GET IT
Times cited: 116
Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET. International journal of radiation oncology, biology, physics. 2011 Academic Article GET IT
Times cited: 80
Phase II study of saracatinib (AZD0530) for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). Anticancer research. 2011 Academic Article GET IT
Times cited: 75
Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. International journal of radiation oncology, biology, physics. 2010 Academic Article GET IT
Times cited: 158
Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review. The Lancet. Oncology. 2010 Review GET IT
Times cited: 278
Tissue microarray evidence of association between p16 and phosphorylated eIF4E in tonsillar squamous cell carcinoma. Head & neck. 2010 Academic Article GET IT
Times cited: 17
Viable tumor in postchemoradiation neck dissection specimens as an indicator of poor outcome. Head & neck. 2010 Academic Article GET IT
Times cited: 26
Her-2/neu expression in testicular cancer--a retrospective analysis in 57 cases. Urology. 2010 Academic Article GET IT
Times cited: 2
Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer. International journal of radiation oncology, biology, physics. 2010 Academic Article GET IT
Times cited: 121
A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer. Cancer. 2010 Academic Article GET IT
Times cited: 9
Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial. International journal of radiation oncology, biology, physics. 2010 Academic Article GET IT
Times cited: 72
Harvesting the low-hanging fruit: kinase inhibitors for therapy of advanced medullary and nonmedullary thyroid cancer. The Journal of clinical endocrinology and metabolism. 2010 Editorial Article GET IT
Times cited: 20
Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 127
[American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer. 2010 Academic Article GET IT
Times cited: 12
Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 444
Reirradiation of locally recurrent nasopharynx cancer with external beam radiotherapy with or without brachytherapy. International journal of radiation oncology, biology, physics. 2010 Academic Article GET IT
Times cited: 62
American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. 2009 GET IT
Times cited: 666
Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases. International journal of radiation oncology, biology, physics. 2009 Academic Article GET IT
Times cited: 87
Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Review GET IT
Times cited: 108
Predictors of outcome for advanced-stage supraglottic laryngeal cancer. Head & neck. 2009 Academic Article GET IT
Times cited: 34
Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience. International journal of radiation oncology, biology, physics. 2009 Academic Article GET IT
Times cited: 94
The role of pretreatment percutaneous endoscopic gastrostomy in facilitating therapy of head and neck cancer and optimizing the body mass index of the obese patient. JPEN. Journal of parenteral and enteral nutrition. 2009 Academic Article GET IT
Times cited: 47
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 103
Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer. American journal of clinical oncology. 2008 Academic Article GET IT
Times cited: 19
Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers. International journal of radiation oncology, biology, physics. 2008 Academic Article GET IT
Times cited: 97
Head and neck cancers. 2008 GET IT
Times cited: 35
Refractory thyroid cancer: a paradigm shift in treatment is not far off. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Editorial Article GET IT
Times cited: 55
Individualized treatment selection in patients with head and neck cancer: do molecular markers meet the challenge?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Editorial Article GET IT
Times cited: 11
Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities. International journal of radiation oncology, biology, physics. 2008 Academic Article GET IT
Times cited: 75
Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2008 Academic Article GET IT
Times cited: 220
Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy. International journal of radiation oncology, biology, physics. 2007 Academic Article GET IT
Times cited: 70
A phase-I trial of the epidermal growth factor receptor directed bispecific antibody MDX-447 without and with recombinant human granulocyte-colony stimulating factor in patients with advanced solid tumors. Cancer immunology, immunotherapy : CII. 2007 Academic Article GET IT
Times cited: 70
Cisplatin versus carboplatin for patients with metastatic non-small-cell lung cancer--an old rivalry renewed. Journal of the National Cancer Institute. 2007 Editorial Article GET IT
Times cited: 29
Skin squamous cell cancer: the time is right for greater involvement of the medical oncologist. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Editorial Article GET IT
Times cited: 3
Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. International journal of radiation oncology, biology, physics. 2007 Academic Article GET IT
Times cited: 118
Identification of angiogenesis/metastases genes predicting chemoradiotherapy response in patients with laryngopharyngeal carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 33
Salvage re-irradiation for recurrent head and neck cancer. International journal of radiation oncology, biology, physics. 2007 Academic Article GET IT
Times cited: 211
A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. International journal of radiation oncology, biology, physics. 2006 Academic Article GET IT
Times cited: 133
A Phase II study of SU5416 in patients with advanced or recurrent head and neck cancers. Investigational new drugs. 2006 Academic Article GET IT
Times cited: 72
A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors. Cancer chemotherapy and pharmacology. 2006 Academic Article GET IT
Times cited: 48
American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. 2006 GET IT
Times cited: 414
Head and neck cancer: recent advances and new standards of care. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 76
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 292
Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer. 2006 Academic Article GET IT
Times cited: 133
Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancer. Cancer journal (Sudbury, Mass.). 2006 Academic Article GET IT
Times cited: 33
Induction chemotherapy for larynx preservation: patient selection or therapeutic effect?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Editorial Article GET IT
Times cited: 18
Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 481
Adjuvant chemo- and radiotherapy for poor prognosis head and neck squamous cell carcinomas. Critical reviews in oncology/hematology. 2005 Review GET IT
Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. International journal of radiation oncology, biology, physics. 2005 Academic Article GET IT
Times cited: 379
Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. International journal of radiation oncology, biology, physics. 2005 Academic Article GET IT
Times cited: 250
Postoperative complications of salvage total laryngectomy. Cancer. 2005 Academic Article GET IT
Times cited: 242
Head and neck cancers. 2005 GET IT
Times cited: 31
Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Academic Article GET IT
Times cited: 47
Clinical practice. Surveillance strategies after curative treatment of colorectal cancer. The New England journal of medicine. 2004 Review GET IT
Times cited: 138
Using patients as their own controls for cost evaluation of phase I clinical trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Academic Article GET IT
Times cited: 3
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Review GET IT
Times cited: 1375
Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynx. Annals of surgery. 2003 Academic Article GET IT
Times cited: 53
The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue. Clinical cancer research : an official journal of the American Association for Cancer Research. 2003 Academic Article GET IT
Times cited: 74
Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 35
Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposure. BMC genetics. 2002 Academic Article GET IT
Times cited: 18
Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 263
Improved outcomes in patients with osteogenic sarcoma of the head and neck. Cancer. 2002 Academic Article GET IT
Times cited: 129
American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Review GET IT
Times cited: 189
Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas. The American journal of pathology. 2002 Academic Article GET IT
Times cited: 77
Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 61
Prediction of survival in patients with head and neck cancer using the histoculture drug response assay. Head & neck. 2002 Academic Article GET IT
Times cited: 66
A phase II trial of bryostatin-1 in patients with metastatic or recurrent squamous cell carcinoma of the head and neck. Investigational new drugs. 2002 Academic Article GET IT
Times cited: 21
Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2001 Academic Article GET IT
Times cited: 312
Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma. International journal of radiation oncology, biology, physics. 2001 Academic Article GET IT
Times cited: 63
Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin. Clinical cancer research : an official journal of the American Association for Cancer Research. 2001 Academic Article GET IT
Times cited: 3
Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. 2001 GET IT
Times cited: 755
Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 70
The Collection of Indirect and Nonmedical Direct Costs (COIN) form: a new tool for collecting the invisible costs of androgen independent prostate carcinoma. Cancer. 2001 Academic Article GET IT
Times cited: 31
A new intensified therapeutic regimen for advanced head and neck squamous cell carcinomas: where does it fit among available treatment options?. Cancer investigation. 2001 Editorial Article GET IT
NCCN Practice Guidelines for Head and Neck Cancers. 2000 GET IT
Times cited: 72
2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. 2000 GET IT
Times cited: 139
Initial clinical trial of a high-affinity retinoic acid receptor ligand (LGD1550). Clinical cancer research : an official journal of the American Association for Cancer Research. 2000 Academic Article GET IT
Times cited: 12
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel. 2000 GET IT
Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer. International journal of radiation oncology, biology, physics. 2000 Academic Article GET IT
Times cited: 53
Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2000 Academic Article GET IT
Times cited: 680
Workshop report: organ preservation strategies in advanced head and neck cancer--current status and future directions. Head & neck. 1999 Conference Paper GET IT
Times cited: 32
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer. 1999 Academic Article GET IT
Times cited: 335
American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. 1999 GET IT
Times cited: 325
Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. 1999 GET IT
Times cited: 628
Clinical economics of head and neck malignancies. Hematology/oncology clinics of North America. 1999 Review GET IT
Times cited: 6
American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Review GET IT
Times cited: 159
Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. 1999 GET IT
Long term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of tongue. Head & neck. 1998 Academic Article GET IT
Times cited: 89
A prospective phase II trial of concomitant chemotherapy and radiotherapy with delayed accelerated fractionation in unresectable tumors of the head and neck. Head & neck. 1998 Academic Article GET IT
Times cited: 49
NCCN practice guidelines for head and neck cancer. National Comprehensive Cancer Network. 1998 GET IT
Times cited: 26
Health services research in head and neck cancer. Cancer treatment and research. 1998 Review GET IT
Times cited: 1
Phase II trial of paclitaxel in patients with soft-tissue sarcoma. Cancer investigation. 1998 Academic Article GET IT
Times cited: 102
The role of chemotherapy in the curative treatment of head and neck cancer. Surgical oncology clinics of North America. 1997 Review GET IT
Times cited: 18
Long-term regional control after radiation therapy and neck dissection for base of tongue carcinoma. International journal of radiation oncology, biology, physics. 1997 Academic Article GET IT
Times cited: 54
Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head & neck. 1997 Academic Article GET IT
Times cited: 195
Economic considerations in the care of patients with head and neck malignancies. Current opinion in oncology. 1997 Review GET IT
Times cited: 10
Initial clinical trial of a selective retinoid X receptor ligand, LGD1069. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997 Academic Article GET IT
Times cited: 187
High-dose edatrexate with oral leucovorin rescue: a phase I and clinical pharmacological study in adults with advanced cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 1996 Academic Article GET IT
Times cited: 2
Outcomes research studies. Oncology (Williston Park, N.Y.). 1996 Academic Article GET IT
Times cited: 10
Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer. Head & neck. 1996 Academic Article GET IT
Times cited: 90
Salvage laryngectomy for unsuccessful larynx preservation therapy. The Annals of otology, rhinology, and laryngology. 1995 Academic Article GET IT
Times cited: 32
Suramin and hydrocortisone: determining drug efficacy in androgen-independent prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Academic Article GET IT
Times cited: 29
Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy. American journal of clinical oncology. 1995 Academic Article GET IT
Times cited: 5
Chemotherapy for recurrent disease and combined modality therapies for head and neck cancer. Current opinion in oncology. 1995 Review GET IT
Times cited: 4
Organ-function preservation in advanced oropharynx cancer: results with induction chemotherapy and radiation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Academic Article GET IT
Times cited: 54
Chemotherapy in locally advanced, squamous cell head and neck cancer: limitations, lessons learned, and evolving standards of care. Cancer investigation. 1995 Editorial Article GET IT
Times cited: 2
Larynx preservation with combined chemotherapy and radiation therapy in advanced hypopharynx cancer. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 1994 Academic Article GET IT
Times cited: 52
Cisplatin, fluorouracil, and leucovorin. Increased toxicity without improved response in squamous cell head and neck cancer. Archives of otolaryngology--head & neck surgery. 1994 Academic Article GET IT
Times cited: 35
Management of unresectable malignant tumors at the skull base using concomitant chemotherapy and radiotherapy with accelerated fractionation. Skull base surgery. 1994 Academic Article GET IT
Neoplastic seeding as a complication of percutaneous endoscopic gastrostomy. 1994 GET IT
Times cited: 45
The management of the clinically positive neck as part of a larynx preservation approach. International journal of radiation oncology, biology, physics. 1993 Review GET IT
Times cited: 55
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1993 Academic Article GET IT
Times cited: 306
A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer. Investigational new drugs. 1993 Academic Article GET IT
Times cited: 4
Base-of-tongue cancer treated with external beam irradiation plus brachytherapy: oncologic and functional outcome. Radiology. 1992 Academic Article GET IT
Times cited: 79
Current status of larynx preservation with multimodality therapy. Oncology (Williston Park, N.Y.). 1992 Academic Article GET IT
Times cited: 18
Neoadjuvant chemotherapy in head and neck cancer: no way to preserve a larynx. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Letter GET IT
Times cited: 18
Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer. International journal of radiation oncology, biology, physics. 1991 Academic Article GET IT
Times cited: 49
Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1991 Academic Article GET IT
Times cited: 124
Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies. 1991 GET IT
Times cited: 64
Chemotherapy as part of the initial treatment for nasopharyngeal cancer. Oncology (Williston Park, N.Y.). 1991 Review GET IT
Times cited: 12
BOMM: new solution or old problem?. Cancer investigation. 1991 Editorial Article GET IT
Chemotherapy and the management of locally advanced squamous cell carcinoma of the head and neck: role in larynx preservation. Important advances in oncology. 1991 Review GET IT
Times cited: 8
Classifying clinical severity to help solve problems of stage migration in nonconcurrent comparisons of lung cancer therapy. Cancer research. 1990 Academic Article GET IT
Times cited: 12
Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors. Cancer. 1990 Academic Article GET IT
Times cited: 31
Diagnostic criteria and technology as sources for changing incidences of pulmonary diseases. The American journal of medicine. 1990 Academic Article GET IT
Times cited: 4
New strategies for avoiding total laryngectomy in patients with head and neck cancer. NCI monographs : a publication of the National Cancer Institute. 1988 Academic Article GET IT
Times cited: 12
Very-high-dose cisplatin with bleomycin infusion as initial treatment of advanced head and neck cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1987 Academic Article GET IT
Times cited: 22
The rightward shift of colon cancer. Aging or artifact?. Journal of clinical gastroenterology. 1987 Academic Article GET IT
Times cited: 12
Biological amine transport in chromaffin ghosts. Coupling to the transmembrane proton and potential gradients. The Journal of biological chemistry. 1979 Academic Article GET IT
Times cited: 60

more ...

less ...

Background

education and training

M.D., University of Pennsylvania School of Medicine 1982
A.B., Dartmouth College 1977

Contact

full name

David Pfister

VIVO Weill Cornell Medical College

David Pfister Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name